SCHEMBL7093699

SCHEMBL7093699

Nc1cccc(C(=O)Nc2cccc3cnccc23)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.59
MEN1 O00255 1/20 0.59
MAPK1 P28482 1/20 0.59
BLM P54132 1/20 0.59
KMT2A Q03164 1/20 0.59
TRPV1 Q8NER1 9/20 0.58
SMN1; SMN2 Q16637 2/20 0.53
CNR1 P21554 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
HSD17B10 Q99714 1/20 0.53
NPC1 O15118 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
RAB9A P51151 1/20 0.51
KDM4E B2RXH2 2/20 0.51
MAPT P10636 2/20 0.51
ALDH1A1 P00352 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17737359 0.86 KMT2A (0.76) HTTMEN1MAPK1BLMKMT2A
SCHEMBL10397739 0.85 NPC1 (0.71) MEN1KMT2ASMN1; SMN2NPSR1HSD17B10
SCHEMBL4433476 0.80 TRPV1 (0.65) HTTMEN1MAPK1BLMKMT2A
SCHEMBL11730609 0.79 LMNA (0.65) MEN1KMT2ATRPV1SMN1; SMN2CNR1
SCHEMBL27583486 0.79 NPC1 (0.72) HTTMEN1MAPK1BLMKMT2A
SCHEMBL4422188 0.79 KMT2A (0.66) HTTMEN1MAPK1BLMKMT2A
SCHEMBL2315592 0.79 KDM4E (0.67) HTTMEN1MAPK1BLMKMT2A
SCHEMBL30544195 0.79 KDM4E (0.67) HTTMEN1MAPK1BLMKMT2A
SCHEMBL5660097 0.78 TRPV1 (0.71) TRPV1
SCHEMBL17744840 0.78 SMN1; SMN2 (0.71) MEN1MAPK1KMT2ASMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6638921-B1 Pharmaceutically acceptable derivatives thereof Cx, R1 and R2 being as defined in the disclosure may be used to inhibit the activity of HIV integrase. PHARMACOR INC. (CA) 2003-10-28 US disclosed
WO-2003082881-A2 PYRIDOXAL-5-PHOSPHATE DERIVATIVES AS HIV INTEGRASE INHIBITORS PROCYON BIOPHARMA INC. (CA) 2003-10-09 WO disclosed